Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing Solid Tumors

Clinical trial NCT07589530 · RECRUITING

Trial details

NCT number: NCT07589530
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumors Metastatic Solid Tumors TROP2-Expressing Solid Tumors

Start date: 2026-03-02
Primary completion: 2027-02-14
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.